TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 22 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -27.1% | 206 | 0.0% | 0.00% | – |
| Q2 2023 | $133 | -21.8% | 206 | 0.0% | 0.00% | – |
| Q1 2023 | $170 | +5.6% | 206 | 0.0% | 0.00% | – |
| Q4 2022 | $161 | – | 206 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 206 | -8.0% | 0.00% | – |
| Q4 2021 | $0 | – | 224 | +8.7% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 206 | -25.4% | 0.00% | – |
| Q2 2021 | $1,000 | – | 276 | +100.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 138 | -97.7% | 0.00% | – |
| Q4 2020 | $20,000 | – | 6,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $22 | 0.00% |
| Renaissance Technologies | 36,510 | $35,000 | 0.00% |
| BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
| VANGUARD GROUP INC | 206,428 | $197,000 | 0.00% |
| UBS Group AG | 7,123 | $7,000 | 0.00% |
| IFP Advisors, Inc | 844 | $3,000 | 0.00% |